Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Bioconnect Systems
AddedFeb 15, 2024
UpdatedJun 18, 2026
Bioconnect Systems

Bioconnect Systems

Bioconnect Systems, Inc. develops specialized medical devices for optimized vascular access in hemodialysis patients.

HQ
Fort Washington, PA, US
Founded
2006
Overview
Compare
Fundraising
Employees

Bioconnect Systems, Inc. develops specialized medical devices to optimize vascular access in hemodialysis patients. Their core product, an anastomotic connector, allows surgeons to create controlled, patient-specific connections. The company primarily serves the United States market.

Bioconnect Systems has made significant strides in improving surgical outcomes for hemodialysis patients. Their innovative technology has been well-received in the medical community, enhancing the efficiency and reliability of vascular access procedures.

Bioconnect Systems - Similar Companies

Hemova Medical logo

Hemova Medical

Catheter Connections logo

Catheter Connections

Phraxis logo

Phraxis

phraxis.com

Bi02 Medical logo

Bi02 Medical

bio2medical.com

Voyager Biomedical logo

Voyager Biomedical

Vascular Therapies logo

Vascular Therapies

vasculartx.com

Buck Surgical logo

Buck Surgical

bucksurgical.com

Bluegrass Vascular Technologies logo

Bluegrass Vascular Technologies

VenoStent logo

VenoStent

venostent.com

CoNextions Medical logo

CoNextions Medical

conextionsmed.com

Avenu Medical logo

Avenu Medical

avenumedical.com

BioInspire Technologies logo

BioInspire Technologies

CathConnect logo

CathConnect

cathconnect.com

Access Vascular logo

Access Vascular

Beta Bionics logo

Beta Bionics

Bioconnect Systems - Quick Facts

Who are Bioconnect Systems' competitors?

Companies similar to Bioconnect Systems include Hemova Medical, Catheter Connections, Phraxis and Bi02 Medical.

When was Bioconnect Systems founded?

Bioconnect Systems was founded in 2006.

Where is Bioconnect Systems' headquarters located?

Bioconnect Systems' headquarters is located in Fort Washington, PA, US.

When was Bioconnect Systems' last funding round?

Bioconnect Systems' most recent funding round was for $9.1M (USD) in September 2013.

How much has Bioconnect Systems raised to-date?

As of Sep 25, 2013, Bioconnect Systems has raised a total of $19M (USD).

How many employees does Bioconnect Systems have?

Bioconnect Systems has 30 employees as of Feb 5, 2024.

Bioconnect Systems - Classification

Industry
  • Hardware
Ownership
  • Private
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Biotech
  • Healthcare
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
ISIC
  • 3250Manufacture of medical and dental instruments and supplies
Show 13 more industry codes
NAICS
  • 339100Medical Equipment and Supplies Manufacturing
  • 339110Medical Equipment and Supplies Manufacturing
  • 339112Surgical and Medical Instrument Manufacturing
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 339000Miscellaneous Manufacturing
  • 623000Nursing and Residential Care Facilities
SIC
  • 3840Surgical, Medical, And Dental Instruments And Supplies
  • 3841Surgical And Medical Instruments And Apparatus
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified